MODULATION OF 5-FU METABOLISM IN HUMAN MCF-7 BREAST-CARCINOMA CELLS

被引:30
作者
MAJOR, PP
EGAN, EM
SARGENT, L
KUFE, DW
机构
[1] HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV PHARMACOL, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV MED, BOSTON, MA 02115 USA
关键词
D O I
10.1007/BF00292877
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:87 / 91
页数:5
相关论文
共 15 条
[1]  
ANSFIELD F, 1977, CANCER-AM CANCER SOC, V39, P34, DOI 10.1002/1097-0142(197701)39:1<34::AID-CNCR2820390107>3.0.CO
[2]  
2-2
[3]   ENHANCED 5-FLUOROURACIL NUCLEOTIDE FORMATION AFTER METHOTREXATE ADMINISTRATION - EXPLANATION FOR DRUG SYNERGISM [J].
CADMAN, E ;
HEIMER, R ;
DAVIS, L .
SCIENCE, 1979, 205 (4411) :1135-1137
[4]  
COX D, 1969, ANAL BINARY DATA, P76
[5]   5-FLUOROURACIL IN CANCER - AN IMPROVED REGIMEN [J].
HORTON, J ;
OLSON, KB ;
SULLIVAN, J ;
REILLY, C ;
SHNIDER, B .
ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) :897-+
[6]  
KORNBERG A, 1955, J BIOL CHEM, V215, P389
[7]  
KUFE DW, 1981, J BIOL CHEM, V256, P9802
[8]  
KUFE DW, 1980, J BIOL CHEM, V255, P8997
[9]   ENHANCEMENT OF 5-FLUOROURACIL INCORPORATION INTO HUMAN LYMPHOBLAST RIBONUCLEIC-ACID [J].
KUFE, DW ;
EGAN, EM .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (02) :129-133
[10]  
MARTIN DS, 1980, CANCER, V45, P1117, DOI 10.1002/1097-0142(19800315)45:5+<1117::AID-CNCR2820451316>3.0.CO